FDA Device recall Z-0528-2014
Oxoid Antimicrobial Susceptibility Test Discs, CTO425B Ciprofloxacin CIP 5 mcg, 50 discs per cartridge, 5 cartridges per box
- FDA Device
- Class III
- terminated
- Published 2013-12-25
On 2013-12-25 the FDA classified a Class III recall of Oxoid Antimicrobial Susceptibility Test Discs, CTO425B Ciprofloxacin CIP 5 mcg, 50 discs per cartridge, 5 cartridges per box by Remel, citing boxes labeled as CIP5 may contain cartridges of AMP5.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0528-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-11-21 |
| Published | 2013-12-25 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Remel |
| Distribution | US |
Product
Oxoid Antimicrobial Susceptibility Test Discs, CTO425B Ciprofloxacin CIP 5 mcg, 50 discs per cartridge, 5 cartridges per box. The firm name on the box label is Oxoid Ltd., Basingstoke, UK. Used in the semi-quantitative agar diffusion test method for in vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes.
Reason
Boxes labeled as CIP5 may contain cartridges of AMP5.
Identifiers
| code_info | Lot number: 1220205, exp July 21, 2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0528-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.